Enveric Biosciences, Inc.
Develops novel neuroplastogen drugs for severe mental health and addiction disorders.
ENVB | NDAQ
Overview
Corporate Details
- ISIN(s):
- US02362F3029 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, 2142 CAMBRIDGE
- Website:
- https://www.enveric.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company leverages its unique discovery and development platform, The Psybrary™, to create a robust intellectual property portfolio of novel molecules for specific mental health indications. Enveric's development pipeline is focused on advancing neuroplastogen therapeutics for conditions such as difficult-to-treat mental health disorders and addiction, with lead candidates including EB-003.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Enveric Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Enveric Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Enveric Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
